Company news
Theratechnologies Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Theratechnologies Announces Renewal of Shelf Prospectus and Filing of Registration Statement
December 21, 2023
Toronto Stock Exchange, Theratechnologies Inc., View From The C-Suite
August 21, 2023
Early Warning Report Issued Pursuant to National Instrument 62-103 - Acquisition of Securities of Theratechnologies Inc.
May 19, 2023
Theratechnologies to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 18, 2023
Theratechnologies to focus its commercialization activities on the North American territory
April 27, 2022
Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended
November 23, 2021
Theratechnologies Establishes New At-The-Market Facility
July 23, 2021
Change to Theratechnologies Management
March 2, 2020
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo(TM) (ibalizumab-uiyk) Injection, the First HIV-1 Inhibitor and Long-Acting Monoclonal Antibody for Multidrug Resistant HIV-1
March 6, 2018
Shareholders elect new Board member during Theratechnologies' annual meeting
May 16, 2017
Announcements in conjunction with Theratechnologies annual meeting
May 16, 2017
Theratechnologies announces regretful decision by the Quebec Ministry of Health
June 9, 2016
Cott Corporation and Theratechnologies Under Current Evaluation
July 7, 2010
Investment Industry Regulatory Organization of Canada - Trade Resumption - Theratechnologies - TH
May 28, 2010
Investment Industry Regulatory Organization of Canada - Trading Halt - Theratechnologies Inc. - TH
May 27, 2010
Stocks slump at open
March 24, 2010
"Undervalued" Theratechnologies Inc. (OTC: THTCF) (TSE: TH)
October 22, 2009
Standard & Poor's annonce des modifications aux indices canadiens S&P/TSX
September 11, 2009
Market Regulation Services - Trade Resumption - Theratechnologies Inc. - TH
February 6, 2007
Market Regulation Services - Trading Halt - Theratechnologies Inc. - TH
February 6, 2007
Theratechnologies' common shares now eligible for inclusion in the SMB Growth Stock Plan
November 22, 2005
Theratechnologies: TH9507 Phase 3 study advancing rapidly
October 13, 2005
European pharmaceutical executive joins the Board of Theratechnologies
August 9, 2005
Theratechnologies: Financial results for the second quarter and recent operating highlights
July 13, 2005
Theratechnologies launches Phase III clinical trial for TH9507 (ThGRF) treating HIV-associated lipodystrophy
July 5, 2005
Theratechnologies closes the sale of its investment in Celmed BioSciences
June 20, 2005
Theratechnologies: four scientific posters at the Endocrine Society Annual Meeting
June 6, 2005
Theratechnologies reports on a positive meeting with Health Canada for its ThGRF Phase III program
May 4, 2005
PRESS CONFERENCE - Theratechnologies Inc. - Invitation to Media
April 13, 2005
Theratechnologies: Financial results for the first quarter of 2005 and recent operating highlights
April 13, 2005
PRESS CONFERENCE - Theratechnologies Inc. - Invitation to Media
April 11, 2005
Calls
The 5 newest of 18 calls. Every call is listed under its year.
- Theratechnologies (THTX) Q1 2025 Earnings Call
Apr 9, 2025
Transcript - Theratechnologies (THTX) Q4 2024 Earnings Call
Feb 26, 2025
Transcript - Theratechnologies (THTX) Q3 2024 Earnings Call
Oct 10, 2024
Transcript - Theratechnologies (THTX) Q2 2024 Earnings Call
Jul 10, 2024
Transcript - Theratechnologies (THTX) Q1 2024 Earnings Call
Apr 10, 2024
Transcript